• Babesia bovis AMA-1, MSA-2c and RAP-1 contain conserved B and T-cell epitopes, which generate neutralizing antibodies and a long-lasting Th1 immune response in vaccinated cattle 

      Hidalgo-Ruiz, Mario; Mejia-López, Susana; Pérez-Serrano, Rosa M.; Zaldívar-Lelo de Larrea, Guadalupe; Ganzinelli, Sabrina Belen; Florin-Christensen, Monica; Suarez, Carlos Esteban; Hernández-Ortiz, Rubén; Mercado-Uriostegui, Miguel A.; Rodríguez-Torres, Angelina; Carvajal-Gamez, Bertha I.; Camacho-Nuez, Minerva; Wilkowsky, Silvina Elizabeth; Mosqueda, Juan (Elsevier, 2022-02)
      Vaccines against bovine babesiosis must, ideally, induce a humoral immune response characterized by neutralizing antibodies against conserved epitopes and a cellular Th1 immune response. In Babesia bovis, proteins such as ...
    • In vivo neutralization of bee venom lethality by IgY antibodies 

      Leiva, Carlos Leónidas; Geoghegan, Patricia; Lammer, Mónica; Cangelosi, Adriana; Mariconda, Virginia; Celi Castillo, Ana Beatriz; Brero, Luisa; Chacana, Pablo (Elsevier, 2021-07)
      Bee venom is a complex mixture of molecules, among which melittin and phospholipase A2 (PLA2) are the toxic components involved in envenoming accidents with multiple honeybee stings. Traditionally, the treatment of envenomings ...
    • Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom 

      Leiva, Carlos Leónidas; Cangelosi, Adriana; Mariconda, Virginia; Celi Castillo, Ana Beatriz; Joaquim, Patricia Estefania; Geoghegan, Patricia; Fernandez Miyakawa, Mariano Enrique; Chacana, Pablo (Springer, 2023-02)
      The use of egg yolk antibodies—IgY technology—represents an alternative to the production of mammalian immunoglobulins and has several advantages regarding animal welfare and lower costs of production. The use of adjuvants ...